CDK4 and breast cancer: The amplification of the mitotic kinase AURKA has been identified in 11 out of 41 HR+ breast cancer biopsies from tumors resistant to CDK4/6 inhibitors, including examples of both intrinsic and acquired resistance, with no alterations detected in sensitive samples [60].